Cargando…

Lymphoma monocyte crosstalk via HSP27 to promote immune suppression and chemotherapy resistance

Detalles Bibliográficos
Autores principales:	Zhang, Zhe, Bulur, Peggy, Gustafson, Michael, Gastineau, Dennis, Dietz, Allan, Lin, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292451/ http://dx.doi.org/10.1186/2051-1426-2-S3-P222

Ejemplares similares

Tumor monocyte cross talk promotes lymphoma cell resistance to chemotherapy
por: Zhang, Zhe (Jenny), et al.
Publicado: (2013)

Expression profiling of suppressive monocytes (CD14+HLA-DRlow/neg) in cancer patients
por: Cordes, Stefan F, et al.
Publicado: (2013)

Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance
por: Zhang, Zhe (Jenny), et al.
Publicado: (2015)

Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress
por: Lin, Yi, et al.
Publicado: (2014)

Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies
por: Gustafson, Michael, et al.
Publicado: (2015)

A method for non-overlapping identification of human myeloid derived suppressor cells
por: Gustafson, Michael, et al.
Publicado: (2014)

Ten-color, whole blood flow cytometric analysis of human myeloid subsets; implications for immune monitoring in cancer patients
por: Gustafson, Michael P, et al.
Publicado: (2013)

Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses
por: Laborde, Rebecca R., et al.
Publicado: (2014)

The CD4+/CD14+HLA-DRlo/neg ratio as a prognostic biomarker in cancer patients
por: Dietz, Allan B, et al.
Publicado: (2013)

The Role of Hsp27 in Chemotherapy Resistance
por: Lampros, Marios, et al.
Publicado: (2022)

PReS-FINAL-1019: Inflammatory monocytes induce resistance of effector t cells to suppression
por: Wehrens, EJ, et al.
Publicado: (2013)

Characterization of a the Plasmodium falciparum Hsp70-Hsp90 organising protein
por: Gitau, Grace, et al.
Publicado: (2010)

The CD14(+)HLA-DR(lo/neg) Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
por: Mengos, April E., et al.
Publicado: (2019)

Monocyte Proteomics Reveals Involvement of Phosphorylated HSP27 in the Pathogenesis of Osteoporosis
por: Daswani, Bhavna, et al.
Publicado: (2015)

Dysregulation of immune monocyte responses during sepsis
por: Fiume, D, et al.
Publicado: (2011)

P16-27.Optimization of the expansion of antigen-specific CD8+ T-cells for use in a viral suppression assay
por: Herman, MM, et al.
Publicado: (2009)

Tau-Hsp70 interaction on the single molecule level
por: Kundel, Franziska, et al.
Publicado: (2013)

Lung cancer recruitment of CD14+ cells results in an immunosuppressive phenotype and improved tumor survival under stress conditions
por: Schenk, Erin, et al.
Publicado: (2015)

Crosstalk of cyclic GMP dependent kinase I and BMP signaling
por: Heining, Eva, et al.
Publicado: (2009)

HSP70/J-protein chaperone machines: expression analysis in granulocytes
por: Zgaga-Griesz, A, et al.
Publicado: (2005)

Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of canine B-cell lymphoma
por: Gavazza, Alessandra, et al.
Publicado: (2013)

Characterization of the mechanisms underlying the crosstalk between galectins and notch in gastric cancer
por: Santos, Sofia N, et al.
Publicado: (2013)

Activated CD27+ and CD27- memory B cells accumulate in the joints of patients with juvenile idiopathic arthritis
por: Morbach, H, et al.
Publicado: (2008)

Immune correlates of Varlilumab treated cancer patients are consistent with CD27 costimulatory activity
por: Bullock, Timothy, et al.
Publicado: (2014)

Potential role of heat shock protein 90 (Hsp90) in HIV uncoating
por: Joshi, Pheroze, et al.
Publicado: (2011)

PReS-FINAL-2318: The structural and functional changes of biomembrains of FMF and HSP with children
por: Sargsyan, H, et al.
Publicado: (2013)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
por: Fecek, Ronald J, et al.
Publicado: (2015)

Clarithromycin reverses sepsis-induced immunoparalysis of monocytes
por: Raftogiannis, M, et al.
Publicado: (2009)

Targeted delivery to inflammatory monocytes for efficient RNAi-mediated immuno-intervention in auto-immune arthritis
por: Présumey, Jessy, et al.
Publicado: (2011)

Comprehensive assessment of circulating immune cell populations in response to stereotactic body radiation therapy in patients with liver cancer
por: Gustafson, Michael P., et al.
Publicado: (2017)

Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4(+)CD45RO(+)CD25(+)CD127(low) regulatory T cells
por: Walter, Gina J, et al.
Publicado: (2012)

Cyclic dinucleotides (CDNs) anti-tumors response by activating DC and NK cell crosstalk
por: Fu, Juan, et al.
Publicado: (2014)

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013)

Functional characterization of GM-CSF induced monocyte subsets
por: Däbritz, J, et al.
Publicado: (2008)

The contribution of monocytes/macrophages to HTLV-1 infection and persistence
por: de Castro-Amarante, Maria Fernanda, et al.
Publicado: (2014)

Influence of thiopentone and midazolam on monocyte differentiation into dendritic cells
por: Karcher, C, et al.
Publicado: (2005)

HTLV-1 burden dependent on hijacking monocytes chemotaxis
por: Castro-Amarante, Maria F, et al.
Publicado: (2015)

Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer
por: Galsky, Matthew D, et al.
Publicado: (2015)

27. A new presentation of interstitial lung disease
por: Mason, Alice, et al.
Publicado: (2019)

Role of the Hsp90 cochaperone, FKBPL, in oestrogen receptor signalling and breast cancer growth and survival
por: McKeen, H, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_r6v1fc0gkd9icr3ijei2rm12qm